{
    "2020-10-30": [
        [
            {
                "time": "2020-10-29",
                "original_text": "AbbVie Earnings Top Views On Rising Humira Sales",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Earnings",
                        "Rising",
                        "Humira",
                        "Sales"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "How AbbVie Beat Expectations in Q3",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Beat",
                        "Expectations",
                        "Q3"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "AbbVie Stock Is Rising Because Earnings Got a Botox Shot",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Stock",
                        "Rising",
                        "Earnings",
                        "Botox"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "Analyst Report: AbbVie Inc.",
                "features": {
                    "keywords": [
                        "Analyst",
                        "Report",
                        "AbbVie",
                        "Inc."
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "AbbVie (ABBV) Beats on Q3 Earnings & Sales, Ups 2020 Guidance",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Beats",
                        "Q3",
                        "Earnings",
                        "Sales",
                        "2020",
                        "Guidance"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "AbbVie Posts Stronger-Than-Expected Earnings as Humira Sales Rise 4%",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Stronger-Than-Expected",
                        "Earnings",
                        "Humira",
                        "Sales",
                        "Rise"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "AbbVie (ABBV) Q3 Earnings and Revenues Top Estimates",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Q3",
                        "Earnings",
                        "Revenues",
                        "Top",
                        "Estimates"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "AbbVie: Q3 Earnings Insights",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Q3",
                        "Earnings",
                        "Insights"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "AbbVie beats earnings expectations, raises its outlook and boosts dividend",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "beats",
                        "earnings",
                        "expectations",
                        "raises",
                        "outlook",
                        "boosts",
                        "dividend"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "AbbVie raises profit outlook on Botox recovery signs, new drugs growth",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "raises",
                        "profit",
                        "outlook",
                        "Botox",
                        "recovery",
                        "new",
                        "drugs",
                        "growth"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "AbbVie raises 2020 profit forecast as COVID-19 hit eases",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "raises",
                        "2020",
                        "profit",
                        "forecast",
                        "COVID-19",
                        "hit",
                        "eases"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "AbbVie Reports Third-Quarter 2020 Financial Results",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Reports",
                        "Third-Quarter",
                        "2020",
                        "Financial",
                        "Results"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "AbbVie, Inc. to Host Earnings Call",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Inc.",
                        "Host",
                        "Earnings",
                        "Call"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "2 No-Brainer Dividend Stocks Yielding More Than 4%",
                "features": {
                    "keywords": [
                        "No-Brainer",
                        "Dividend",
                        "Stocks",
                        "Yielding",
                        "More",
                        "Than",
                        "4%"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}